Integrated BioPharma, Inc. (OTCMKTS:INBP) Short Interest Down 83.3% in February

Integrated BioPharma, Inc. (OTCMKTS:INBP) saw a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 400 shares, a decrease of 83.3% from the January 31st total of 2,400 shares. Based on an average daily trading volume, of 69,500 shares, the days-to-cover ratio is presently 0.0 days.

Integrated BioPharma Price Performance

Integrated BioPharma stock traded up $0.01 during mid-day trading on Friday, reaching $0.30. The company had a trading volume of 38,467 shares, compared to its average volume of 20,255. The stock’s 50-day simple moving average is $0.34 and its 200-day simple moving average is $0.29. Integrated BioPharma has a 1 year low of $0.16 and a 1 year high of $0.42. The company has a market capitalization of $8.94 million, a P/E ratio of 9.84 and a beta of 0.62.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.